Ramachandran Niro Ph.D's Form 4 filing
Akoya Biosciences, Inc. (AKYA) · filed Nov 22, 2021
- Accession no.
- 0001104659-21-142696
- Filed
- Nov 22, 2021
- Trade date
- Nov 19-22, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $329.2K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ramachandran Niro Ph.DCIK 0001857443 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 | Common Stock | PPurchaseAcquired | +73 | $12.85 | +$938.05 | 73 | Direct | |
| Nov 22, 2021 | Common Stock | PPurchaseAcquired | +25,000 | $13.13F1 | +$328,250 | 25,073 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Column 4 reflects a weighted average price. Shares were sold in multiple transactions at prices ranging from $12.94-$13.1699. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within ranges set forth herein.
Referenced by the price of 1 transaction in Table I.